Protiva Biotherapeutics

Drug development using non-viral lipid-mediated gene delivery.

Contact Details: 150 - 8900 Glenlyon Parkway Burnaby British Columbia V5J 5J8 Canada Tel: Fax: Email: WWW: www.protivabio.com/

Loading...

Recent Publications by Protiva Biotherapeutics:
Hypersensitivity and loss of disease site targeting caused by antibody responses to PEGylated liposomes. The systemic application of nucleic acid drugs requires delivery systems...	24th January, 2009	Protiva Biotherapeutics, Burnaby, BC, Canada.	Mol Ther. 2006 Feb;13(2):328-37. Epub 2005 Nov 7. DOI Direct Link
Overcoming the innate immune response to small interfering RNA. Many types of nucleic acid, including canonical small interfering RNA...	18th September, 2008	Protiva Biotherapeutics, Burnaby, British Columbia, Canada V5G 4Y1.	Hum Gene Ther. 2008 Feb;19(2):111-24. DOI Direct Link
2'-O-methyl-modified RNAs act as TLR7 antagonists. RNA molecules such as single-stranded RNA (ssRNA) and small interfering...	27th February, 2008	Protiva Biotherapeutics, Burnaby, British Columbia, Canada.	Mol Ther. 2007 Sep;15(9):1663-9. Epub 2007 Jun 19. DOI Direct Link
Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Targeted silencing of disease-associated genes by synthetic short...	1st August, 2007	Protiva Biotherapeutics, 100-3480 Gilmore Way, Burnaby, BC, Canada V5G	Mol Ther. 2006 Mar;13(3):494-505. Epub 2005 Dec 15. DOI Direct Link
Lipid encapsulation enables the effective systemic delivery of polyplex plasmid DNA. Using a new controlled mixing process, highly transfection-competent...	23rd May, 2007	Protiva Biotherapeutics, Burnaby, British Columbia, Canada.	Mol Ther. 2007 Apr;15(4):713-20. Epub 2007 Feb 13. DOI Direct Link
→View more Protiva Biotherapeutics research publications.

Press Releases on Protiva Biotherapeutics:
Previous Claims of siRNA Therapeutic Effects Called into Question by Report in 'Human Gene Therapy'	2nd September, 2008	Mary Ann Liebert, Inc.	NEW ROCHELLE, N.Y., Sept. 2 /PRNewswire/ -- The many recent reports documenting the therapeutic efficacy of short interfering RNAs (siRNAs) in animal models of human disease may actually be

BioNews Results for Protiva Biotherapeutics:
Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton	Genetic Engineering News:  Nov 15 2009 8:17AM Matching: biotherapeutics
Drug firm expanding NC operation, adding 260 jobs	WCNC:  Nov 15 2009 2:58AM Matching: biotherapeutics
Rockland job losses could hit 600 by 2011	Lower Hudson Online:  Nov 14 2009 10:50PM Matching: biotherapeutics
Talecris to Invest $268.7 Million to Expand its Manufacturing Facility in Clayton	Pharma Live:  Nov 14 2009 10:40PM Matching: biotherapeutics
Drug firm expanding N.C. operations, adding 260 jobs	Fayetteville Online:  Nov 14 2009 5:13PM Matching: biotherapeutics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Protiva Biotherapeutics news.

Protiva Biotherapeutics Patents:
US Patent No.	Title
6841537	Combination therapy using nucleic acids and conventional drugs
6410328	Sensitizing cells to compounds using lipid-mediated gene and compound delivery

Protiva Biotherapeutics (PRW) Financial information Links from Barchart
PRW Quote from from Barchart.com
PRW Chart from from Barchart.com
PRW Profile from from Barchart.com
PRW Opinion from from Barchart.com
→View more Protiva Biotherapeutics finance information.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 505 times since April 2007, the link to the organisation's website has been followed 93 times

Recent Search Terms used to find this page: Protiva Biotherapeutics | protiva | protiva b | biotherapeutics process development jobs,canada | protiva | .

Search for more companies in Burnaby

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Protiva Biotherapeutics